Monalizumab Biosimilar（Anti-NKG2A / CD94 Reference Antibody）

• Catalog Number: orb2704016
• Category: Antibodies
• Description: Monalizumab (IPH2201) is an immune checkpoint inhibitor targeting Natural Killer Group 2A (NKG2A). Monalizumab, a humanized anti-NKG2A blocking mAb, increases IFN-γ production, thereby promoting NK cell effector functions. Monalizumab can be used for the research of head and neck squamous cell carcinoma (HNSCC).
• Target: Monalizumab Biosimilar（Anti-NKG2A / CD94 Reference Antibody）
• Conjugation: Unconjugated
• Antibody Type: Biosimilar Antibody
• CAS Number: [1228763-95-8]
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only